The effect of methadone dose regimen on neonatal abstinence syndrome

John J. McCarthy, Martin H Leamon, Neil H. Willits, Ruth Salo

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objectives: To evaluate the effects of a multiple daily dose methadone regimen in pregnancy on neonatal outcomes. Methods: Although methadone maintenance has been the standard for the treatment of opioid dependence in pregnancy, there is no consensus on proper dosing. Single daily dosing is the most common strategy. Because of accelerated metabolism of methadone in pregnancy, this regimen may expose mother and fetus to daily episodes of withdrawal and possibly contribute to more severe Neonatal Abstinence Syndrome (NAS). This study reports on a protocol that increased both methadone dose and dose frequency in response to maternal reports of withdrawal. Results: Treatment of NAS was needed in 29% of neonates, compared to a published rate of 60% to 80%. The mean methadone dose was 152 mg at delivery, divided into 2 to 6 doses per day. Ninety-two percent of mothers were free of illicit drug use at delivery. There was no relationship between methadone dose and treatment of NAS. Female babies had a treatment rate of 16% versus 38% for male babies. Beyond abstinence symptoms, cohort outcomes in terms of gestational age, birth weight, prematurity, Caesarian sections, and breastfeeding equaled or approximated US population norms. Conclusions: The protocol was associated with low rates of treatment of NAS and high rates of maternal recovery. High rates of treatment for NAS reported in methadone-exposed neonates might relate in part to iatrogenic factors and be reduced through the use of divided daily doses and protocols that minimize maternal withdrawal.

Original languageEnglish (US)
Pages (from-to)105-110
Number of pages6
JournalJournal of Addiction Medicine
Volume9
Issue number2
DOIs
StatePublished - Dec 1 2015

Fingerprint

Neonatal Abstinence Syndrome
Methadone
Mothers
Pregnancy
Therapeutics
Newborn Infant
Street Drugs
Breast Feeding
Birth Weight
Cesarean Section
Opioid Analgesics
Gestational Age
Consensus
Fetus

Keywords

  • dose regimen
  • methadone
  • neonatal abstinence syndrome
  • pregnancy

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)
  • Medicine(all)

Cite this

The effect of methadone dose regimen on neonatal abstinence syndrome. / McCarthy, John J.; Leamon, Martin H; Willits, Neil H.; Salo, Ruth.

In: Journal of Addiction Medicine, Vol. 9, No. 2, 01.12.2015, p. 105-110.

Research output: Contribution to journalArticle

McCarthy, John J. ; Leamon, Martin H ; Willits, Neil H. ; Salo, Ruth. / The effect of methadone dose regimen on neonatal abstinence syndrome. In: Journal of Addiction Medicine. 2015 ; Vol. 9, No. 2. pp. 105-110.
@article{545fa934ed304857876f817a244dcf1b,
title = "The effect of methadone dose regimen on neonatal abstinence syndrome",
abstract = "Objectives: To evaluate the effects of a multiple daily dose methadone regimen in pregnancy on neonatal outcomes. Methods: Although methadone maintenance has been the standard for the treatment of opioid dependence in pregnancy, there is no consensus on proper dosing. Single daily dosing is the most common strategy. Because of accelerated metabolism of methadone in pregnancy, this regimen may expose mother and fetus to daily episodes of withdrawal and possibly contribute to more severe Neonatal Abstinence Syndrome (NAS). This study reports on a protocol that increased both methadone dose and dose frequency in response to maternal reports of withdrawal. Results: Treatment of NAS was needed in 29{\%} of neonates, compared to a published rate of 60{\%} to 80{\%}. The mean methadone dose was 152 mg at delivery, divided into 2 to 6 doses per day. Ninety-two percent of mothers were free of illicit drug use at delivery. There was no relationship between methadone dose and treatment of NAS. Female babies had a treatment rate of 16{\%} versus 38{\%} for male babies. Beyond abstinence symptoms, cohort outcomes in terms of gestational age, birth weight, prematurity, Caesarian sections, and breastfeeding equaled or approximated US population norms. Conclusions: The protocol was associated with low rates of treatment of NAS and high rates of maternal recovery. High rates of treatment for NAS reported in methadone-exposed neonates might relate in part to iatrogenic factors and be reduced through the use of divided daily doses and protocols that minimize maternal withdrawal.",
keywords = "dose regimen, methadone, neonatal abstinence syndrome, pregnancy",
author = "McCarthy, {John J.} and Leamon, {Martin H} and Willits, {Neil H.} and Ruth Salo",
year = "2015",
month = "12",
day = "1",
doi = "10.1097/ADM.0000000000000099",
language = "English (US)",
volume = "9",
pages = "105--110",
journal = "Journal of Addiction Medicine",
issn = "1932-0620",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The effect of methadone dose regimen on neonatal abstinence syndrome

AU - McCarthy, John J.

AU - Leamon, Martin H

AU - Willits, Neil H.

AU - Salo, Ruth

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Objectives: To evaluate the effects of a multiple daily dose methadone regimen in pregnancy on neonatal outcomes. Methods: Although methadone maintenance has been the standard for the treatment of opioid dependence in pregnancy, there is no consensus on proper dosing. Single daily dosing is the most common strategy. Because of accelerated metabolism of methadone in pregnancy, this regimen may expose mother and fetus to daily episodes of withdrawal and possibly contribute to more severe Neonatal Abstinence Syndrome (NAS). This study reports on a protocol that increased both methadone dose and dose frequency in response to maternal reports of withdrawal. Results: Treatment of NAS was needed in 29% of neonates, compared to a published rate of 60% to 80%. The mean methadone dose was 152 mg at delivery, divided into 2 to 6 doses per day. Ninety-two percent of mothers were free of illicit drug use at delivery. There was no relationship between methadone dose and treatment of NAS. Female babies had a treatment rate of 16% versus 38% for male babies. Beyond abstinence symptoms, cohort outcomes in terms of gestational age, birth weight, prematurity, Caesarian sections, and breastfeeding equaled or approximated US population norms. Conclusions: The protocol was associated with low rates of treatment of NAS and high rates of maternal recovery. High rates of treatment for NAS reported in methadone-exposed neonates might relate in part to iatrogenic factors and be reduced through the use of divided daily doses and protocols that minimize maternal withdrawal.

AB - Objectives: To evaluate the effects of a multiple daily dose methadone regimen in pregnancy on neonatal outcomes. Methods: Although methadone maintenance has been the standard for the treatment of opioid dependence in pregnancy, there is no consensus on proper dosing. Single daily dosing is the most common strategy. Because of accelerated metabolism of methadone in pregnancy, this regimen may expose mother and fetus to daily episodes of withdrawal and possibly contribute to more severe Neonatal Abstinence Syndrome (NAS). This study reports on a protocol that increased both methadone dose and dose frequency in response to maternal reports of withdrawal. Results: Treatment of NAS was needed in 29% of neonates, compared to a published rate of 60% to 80%. The mean methadone dose was 152 mg at delivery, divided into 2 to 6 doses per day. Ninety-two percent of mothers were free of illicit drug use at delivery. There was no relationship between methadone dose and treatment of NAS. Female babies had a treatment rate of 16% versus 38% for male babies. Beyond abstinence symptoms, cohort outcomes in terms of gestational age, birth weight, prematurity, Caesarian sections, and breastfeeding equaled or approximated US population norms. Conclusions: The protocol was associated with low rates of treatment of NAS and high rates of maternal recovery. High rates of treatment for NAS reported in methadone-exposed neonates might relate in part to iatrogenic factors and be reduced through the use of divided daily doses and protocols that minimize maternal withdrawal.

KW - dose regimen

KW - methadone

KW - neonatal abstinence syndrome

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=84945128652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945128652&partnerID=8YFLogxK

U2 - 10.1097/ADM.0000000000000099

DO - 10.1097/ADM.0000000000000099

M3 - Article

C2 - 25599433

AN - SCOPUS:84945128652

VL - 9

SP - 105

EP - 110

JO - Journal of Addiction Medicine

JF - Journal of Addiction Medicine

SN - 1932-0620

IS - 2

ER -